FDA Inspection 1297222 — Emilie Kaczmarek, MD
The FDA completed an inspection of Emilie Kaczmarek, MD on December 5, 2025 in Lille. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lille (France)
Additional Details
Clinical Investigator (CI)